Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

Background Inflammation and hyperlipidaemia jointly contribute to atherothrombotic
disease. However, when people are treated with intensive statin therapy, the relative …

Importance It remains uncertain whether the omega-3 fatty acids eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) reduce cardiovascular risk. Objective To determine …

Low-grade inflammation is the hallmark of metabolic disorders such as obesity, type 2
diabetes and nonalcoholic fatty liver disease. Emerging evidence indicates that these …

Gut microbiota and its metabolites such as short chain fatty acids (SCFA),
lipopolysaccharides (LPS), and trimethylamine-N-oxide (TMAO) impact cardiovascular …

Aims The neutrophil–lymphocyte ratio (NLR) is a readily available inflammatory biomarker
that may associate with atherosclerosis and predict cardiovascular (CV) events. The aims of …

Background Inflammation links to atherosclerosis and its complications in various
experimental investigations. Animal studies have implicated numerous inflammatory …

Background Authors were assigned the task to develop case definitions for periodontitis in
the context of the 2017 World Workshop on the Classification of Periodontal and Peri …

Cardiovascular disease is a leading cause of death and reduced quality of life, proven by
the latest data of the Global Burden of Disease Study, and is only gaining in prevalence …